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HISTORICAL 
Compounds a ff ecting the ut ilization of  L-glutamine ( 7 )  have a 
compara t ively long history in the field of  cancer chemotherapy . The 
Streptomyces ant ibio tics , azas erine (1) (0-diazoacetyl-L-serine) and 
DON ( 2 )  ( 6-d iazo-5-oxo-L-norleucine ) inhib it to varying ext ents 
those aminations in which glutamine s erves as an amino group donor . 
This inhib it ion is  achieved in at leas t one case by the glutamine 
antagonists  alkylat ing the sulfhydryl group of the enzyme that cata� 
lyzes the amino group transfer of  glutamine . A dist inguishing 
featur e of the diazo analogs of glutamine is the very reac t ive diazo 
group that enhances nucleophilic reactions on the adjacent carbon 
atom .  A diazo group is represent ed a s  such: 
. (�=�=) 
Because of  the increas ed react ivity created by the d iazo group , the 
diazo analogs of glutamine irrevers ibly inhibi t  the glutamine re-
quiring enzymes . 
Although having gone through exhaust ive clinical t es t s , the L-
glutamine antagonists , azaserine and DON , readily declined in inter-
est b ecause of  their ineffectiveness in treatment of  human malig-
· nancies .  The recent success of  L-asparag inas e in the therapy of 
c er tain human neoplasms has prompted a reconsideration of compounds 
which can alter L-glutamine metabolism becaus e: (1 )  L-glutamine is 
necessary in mos t  mammalian sys tems , for the synthes is of L-
asparagine; ( 2 )  both azaserine and azotomycin appear t o  b e  syner­
gis tic with L-asparaginas e agains t the L5178Y mous e leukemia; and 
• • • : "' � _· � •• I • I • • ' • • ' ' 
(3)  L-asparaginase from E. coli (EC-2) of the form in clinical use 
in the United States has intrinsic L-glutaminase activity. EC-2 . 
preparations appear to be more active again st certain tumor cells 
than. guinea pig or agouti serum preparations that lack L-glutaminase 
activity. Whether thi s  is due to the additional L-glutaminase activ­
ity remains to be proven.1 
The pur po se of making compounds which are structurally similar 
to the two antibi otics i s  threefold. These are to prod uce a com­
pound which (1) is more active again st the tumor , ( 2 )  is les s  toxic 
to the patient and ( 3 )  will help elucidate the mechani sm and nature 
of its bonding to active sites of enzymes in various biological 
rcactians.2 
Tqe hi story is divided into two parts; the first section deals 
with the importance of L-glutamine in metabolic and biosynthetic 
pathways ,  the second part concentrates on glutamine antagonists and 
their inhibit ory effect with the biosynthe sis or metabolic roles of 
the·parent compound. 
I. L-GLUTAMINE 
In 188 3 , Schulze and Bosshard3'4 isolated pure glutamine from 
an aqueou s  extract of beet roots. However , it was not until 1932 
that Chibnall's laboratory5'6 proved the presence of a sparagine and 
of glritamine as normal constituent s of protein . Although L-glutamine 
is  not an es sential dietary amino acid for the intact mammal , it must 
be pre sent in the medium in high concentrations for the maintenance 
2-
of cells in tissues. 
A very important role of glutamine .i s to keep the concentr ation 
of ammonia below a toxic level. This is  done by the· con�ersion of 
g lutamate to g lutam�ne. Th.e formation of glutamine is also used for 
transient storage of part of the nitrogen in the diet. · Most impor-
tant of a ll ,  glutamine serves as an amide group donor for the forma-
tion of numerous compounds. This includes the synthesi s  of purines ,  
pyrimidines and amino sugars found in structural polysaccharides. 
Interference with.the metabolism of glutamine will therefore disturb 
a variety of metabolic pathways. 
There are three positions along the biosynthetic pathway of the 
purine s  ( Scheme I and II) .in which glutamine act s as an amide group 
donor. The nitrogens in the third and ninth position of the purine 
�ing are derived from glutamine. 
C0 2 
.L ,--- -, 
a s p artate ) � C -..! N 1 -...(--- g lycine N , " i'C 1"' 7 ' ' 
f ormyl 
H4 f olate 
) 
I 'JI ,--1c 
c� 3 'c.J.... 11r �<--­�N"'--' N 
v 
glutamine 
methylidine 
H4 f olate 
The third use of glutamine is in the formation of guanosine. In the 
pyrimidine. pathway (Scheme III ) ,  g lutamine is involved on ly in one 
re action. The importance of glutamine's role in the biosynthetic 
pathways is that the formation of purine s and pyrimidines are an 
essential part of the RNA and DNA molecules. 
3 · 
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Biosynthesis of Adenylic and Guanylic Acid 
from Inosinic Acid7 
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In summary , L-glutamine plays a vital role not only as a con­
s t ituent of  prot ein but also furnishing an amide group in es s ential 
react ions in nucleic acid , diphosphopyridine , glucosamine and L­
asparagi�e synthesis de novo . 1 
II . GLUTAMINE ANTAGONISTS 
Cancers are made of cells that continue to d ivide indefinit ely . 
Since cell divis ion requires a net synthes is of nuclei� acids , there 
has been considerable effort made to find compounds that will selec­
tively inh ibi t the formation of nucleic acids and thereby check the 
uncontrolled growth of cancer . Many of the compounds tried for the 
inhibition of purine anci pyrilllidiue biosynthesis have been Jia�o 
compounds . Although the glutamine antagonis ts inhibit purine and 
pyrimid ine biosynthesis to a certain extent in tumor cells , these 
synthes es are also necessary for the maintenance qf
.
normal cells . 
As a resul t , concentrations of the glutamine analogs that are effec­
tive in suppres s ing cancer growth are also very toxic . Cons equently , 
work wi th thes e compounds diminished , until it  was found8'9 that 
combinat ion of a glutamine antagonist  with L-asparaginas e suppressed 
cancer growth . 
A comp arison of the structures of the glutamine antagonists  
(Fig .  1) shows _a marked similarity among the compounds and also  to 
glutamine and asparagine . Each diazo analog is discus sed below as to 
its ef f ectiveness as a glutamine antagonis t  with major emphas is  on 
azas erine and DON . 
7 
S tructural Formulaa of Diazo Antibiot ics1 
1 .  
2 .  
3. 
4 .  
s. 
6 .  
0 
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Figure 1 
Azaserine 
(0-diazoacetyl-
L-serine) 
DON 
(6-diazo-5-oxo-
L-norleucine) 
DONV 
(5-diazo-4-oxo-
norvaline ) 
Duazomycin A 
(N-acetyl-6-
diazo-5-oxo-L-
norleucine 
Azotomycin 
(Duazomycin B )  ·
N- (N-f-glutamyl-
6-diazo-5-oxo­
nor leucinyl ) -6-
diazo-5-oxo-norleucine 
DGA 
(Diazoacetyl 
glyc inamide)  · 
L-glutamine 
L-asparagine 
8 
Probably the mos t  clinically tes ted glutamine antagonis t has 
b een azaserine . Azas erine and DON were 
.
both discover ed independently 
by Ehrlich et · a1 . , and Stock et al . in culture  f iltrates of two 
s pec ies of  S treptomyc es . 10 , 1 1  Synthesis o f  aza$er ine 1 2 has b een 
achieved by s elec t ive diazot ization of 0-glycyl-L-s er ine in 15�20% 
yields . 
The mos t  s ens itive inhibition of an amination react ion by aza-
s erine and DON is the one involving the convers ion of f ormylglycin-
amide r ibonuc leotide (FGAR) to the corresponding amidine (FGAM) . 
H 
(N'cHO 
cf NH 
+ 
I 
Ribose-P 
o(-N-f onnylglyc inamid e 
r ibonuc leotide  
(FGAR) 
ATP ADP+ P. 
glutamine __':.,, Mg2+ J} 1 
H 
C
N'-
CHO 
H20 HN� NH 
• 
Ribos e-P 
D(-N-formylglyc inamidine 
ribonucleo tide 
(FGAM) 
Table I shows the inhibitory effec t of azas erine on three dif f erent 
r eac tions in purine biosynthesis . 
Becaus e of  the inhibition of the FGAR to FGAM react ion by aza-
s erine , mechanisms have been derived to explain the inhibition . 
Baker 1 3 in 1959 sugg ested that azas erine reacts with pyridoxal 
phosphate to form an inactive cofac tor-azaserine complex which pre-
vents pyr idoxamine formation . Pyridoxal phosphate is an ess ential 
coenzyme for the transfer of the amide group from L-glutamine . The . 
prediction by Baker that azas erine alkyla tes the phosphoryl group 
of enzymatically bound pyridoxal phosphate , does not apply to FGAR 
amidotrans feras e . 1 4  In 1963, French and his co-workers 1 5  proposed 
9 
Table I 
Inhibitory Effect of Azaserine 
on Purine Biosynthesis 1 
Azas erine 
Concentration 
(M) 
Reaction 1: 
2 . 9 x 10- 3 
2 . 9  x 10-2 
Reaction 2 :  
5 . 7 x 10- 4 
5 . 7  x 10-9 
Reaction 3: 
5.7 x 10-9 
Reaction 1: Glutamine + PRPP 
Reaction 2: FGAR 
React ion 3: FGAM 
(not L-glutamine dependent ) 
L-Glutamine 
Concentration % Inhibition 
(M) 
2 . 9  x 10- 3 17 
2 . 9 x 10- 3 18 
5 . 7 x 10-9 61 
5 . 7  x io- 3 95  
0 40 
--��) 5-Phosphoribosyl + glutamate 
1-amine 
FGAM 
5-Aminoimidazole  carboxamide 
ribonucleotide 
10 
that azaser ine reacts with FGAR amidotransferas e [2-formamido-N­
r ibosylacetamide 5 ' -phosphate: L-glutamine amido-ligas e (adenos irle 
diphosphate) , (EC 6 . 3 . 5 . 3 )] . Azaser ine alkylates the sulfhydryl 
group of a cys teine res idue of the enzyme preventing the attachment 
of L-glutamine to the enzyme . The reason given for the special 
reactivity of the diazo compounds with the enzyme is that the 
sulfhydryl group of  the enzyme is in just  the right position to be 
at tacked by the carbon of the diazo group . Support of  the latter 
mechanism was made by Mizobuchi and Buchanan 1 6 in 1968. They pre­
sented evidence that the initial binding of glutamine to FGAR amido­
transferas e involves a reversible react ion of the carboxamide carbon 
wit:h t:he sulfhydryl group on the enzyme to yield a l'-glutamyl thio­
ester and ammonia . Also , they showed that the azas erine-enzyme com­
plex formed involved binding at a valylcys teine dipept ide s equence . 
S ince azaserine does not. react with free cys teine,. it  mus t  b e  the 
activation p roces s of the active site which aids the alkylation 
proces s . A compound similar to azas erine , ethyl diazoacetate , reacts 
with water or  alcohol and has a diazoniwn salt as an intermediate .  
Ethyl d iazoacetate does not react with n-butyl mercap tan but does . 
reac t with the more acidic thiophenol , preswnably through a dia­
zonium salt int ermediate . 1 7 Therefore , the reaction of azas erine 
with the specific cys teine res idue of the enzyme probably involves 
the diazonium salt of the inhibitor . Further data 1 5 sugges ted the 
reactive site  of azas erine is the same as that o f  glutamine . Scheme 
IV illus trates how a glutamine antagonist reacts with the enzyme . 
11 -
I 
s 
/ H 
Attack on FGAR Amidotran sf erase 
by DON15 
(Enzyme active site ) 
Scheme IV 
12 
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By analogy to  the mechanism proposed for glutamine antagonis t 
bonding to FGAR amidotransf eras e ,  the mechanism in Scheme V is pro-
pos ed for amide nitrogen trans fer of glutamine . 
The.synthes is of DON18 was achieved by cov�ring the amino and 
ol -carboxyl functions of glutamic acid with appropriate protecting 
groups , converting the Y-carb9xyl of glutamic ac id to  a diazo ketone 
and then removing the protecting group by ·selective hydrolysis . 
DON has b een evaluated almost as extensively as azas erine . 
Moore and LePage 19 reported that relatively large amounts o f  FGAR 
were accumulated by  the actively growing tissues when inhib ited by 
a zaserine . DON in low doses gave similar effects , b ut at  higher 
doses, DON also inhibits at  a point prior to FGAR formation. As in 
the cas e  of azaserine , synthesis of the pyrimidine nucleo tide cyti-
dine is  inhib ited by DON. In 1961, Moore and Hurlb ert 20 showed that 
concentrat ion of DON needed to completely inhib it b iosynthes is of 
cytidine nucl eotides was at leas t ten times that required for b io-
h · f 1 "d They also found that 4. 5 X 10-3 M synt esis o purine nuc eot1 es . 
of  DON in the pres ence of 3 . 0  X 10- s M exogenous L-glutamine com-
pletely inhib ited de  � formation of purine and cytidine nucleo-
t ides by the Novikoff twnor cell suspension , yet the cells were ab le 
to maintain synthesis  of RNA at 60% of their usual r ate . 
DONV (3 ) is  the next lower homolog of DON. It is class ed by 
Handschumacher et al . 2 1 as an analog of L-asparagine . DONV has 
b een succes s ful in competition with L-asparagine for binding sites 
on L-asparaginas e at phys iological pH . In the same exper iment , it 
13 
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was shown that DONV had no effect on L-glutaminase or other L....; 
glutamine-dependent reactions . This, is in contras t to the work done 
by French� al . 1 4 ,  who found DONV to cause 50% inhibit ion of the 
FGAR to FGAM react ion . 
Anderson and Brockman2 2  found that duazomycin A (4 ) inhib ited 
incorporat ion of formate into __ soluble purine nucleo t ides and into 
nucleic acids in growing 70429 cells and produced large accumulations 
of FGAR in the solub le fract ion of these cells . An increase in dos e · 
of  duazomycin A caused les s  accumulation of FGAR. This indicates 
that duazomyc in A inhibits effect ively at an early s tage in the de 
�pathway of purine b iosynthes is . Duazomycin A has also been 
shown22 to be an effective inhibitor of the convers ion of  uridine to 
cytidine nucleotid es but not �s effectively as DON . 
Although only a few unpublished s tudies have b een done on azoto­
mycin 1 ( 5 ) , it  is suppose to have a similar mode  of action to DON and 
azas erine . 
A compound s imilar in structure to azas erine is  diazoacetyl 
glycinamide (DGA) , (6 ) . It displays a marked ant itumor activity on 
the ascites forms of Sarcoma 180 and Ehrlich as cites carcinoma and 
on the Galliera rat sarcoma . 
With a change in s tructure , it  is interesting to  note similari-
ties and/or differences in inhibition of the same process . Aza­
serine inhib its  thymidine incorporat ion into DNA , but not that of 
labelled adenine .  If one increases the supply of  adenine in the 
cells , the inhibit ion of thymidine incorporat ion by azas er
ine is 
15 
removed . DGA, on the other hand , inhibits the incorporation of  
lab elled adenine and thymidine in DNA. Also , adenine does not modify 
the inhibition o f  thymidine incorporation by DNA. This sugges ts 2 3 
that DGA.caus es an inhibi tion of DNA synthesis �y acting on the final 
steps of purine b iosynthesis. The precise nature and localization of 
the s tep at  which the inhibition is exerted are und er inves tigation. 
The compounds which have received clinical trials are primarily 
azaserine , DON , duazomyctn A and azotomycin. They have not proven 
effective enough as sole therapy. The feeling is riow that an L­
glutamine antagonis t in conjunction with L-asparaginas e would be the 
mos t b eneficial means for treatment of malignancies. 
In s tudies of the effectiveness of combination chemo therapy 
agains t L51 78Y , Jacobs et al . 8 , 9 showed that combinations o f  L­
asparaginase plus azaserine or azo tomycin provided a therap eutic 
effect that was markedly superior to that produced· by the individual 
drugs. A numb er of s tudies8'9' 2 4 , 2 5 have shown that tl.llllors (L5178Y) 
with low asparagine synthetas e activity generally require an extra­
cellular source o f  L-asparagine and are s ensitive to L-asparaginas e 
treatment.  Depletion of circulating L-asparagine by the dual pro­
cess of inhibiting a precursor for its extracellular synthesis and 
enhancing its deamidation can lead to a combined respons e agains t a 
tumor· with little or  no asparagine synthetase activity. It  is also 
possible that the s ynergistic action of  glutamine analogs and L­
asparaginas e against L5178Y resulted from L-asparagine-depletion and 
concurrent block o f  de� purine biosynthesis.  
16  
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The primary goal in conducting the experimental work involved 
in the formulation of this thesis was to synthes ize S- (l-diazo-2 ,2 , 2-
trifluoroethyl) cys teine dioxide (16 ) ,  a potential glutamine antag-
onist .  0 0 
CJ© •·- " R:: N::: C - S - CH2- CH-C -OH ' ' ' 
CFs 0 NH2 (16a) 
The reason to pursue this proj ect is the rej uvenated interes t in the 
use of  glutamine antagonists with L-asparaginas e in comb ination. 
chemotherapy . 
The r esonance structure of this compound shows the diazonium 
group and a carbanion . 0 0 
© e I II 
N= N-C - S - CH2- CH-C-OH I l I 
CFs 0 NH2 (16b ) 
Analysis of the group bonded to the carbanion shows two elec tron-
withdrawing groups: 
- CFs and 
0 
l 
- s -
• 0 
Thes e  two groups are able to s tabilize the compound by dispers ing the 
negat ive charge of the carbon atom. Carbanions adj acent to sulfur 
are s tab ilized by back-bonding to the sulfu� atom . As the sulfur 
becomes more elec tropositive in higher coordinat ion s tates , both 
d-orb ital participation and coulombic interac tion contribute to the 
s tability of  the carbanion . 2 6 The stab ilizing effec t  o f  these two 
electron-withdrawing groups is illustrated by compounds · that contain 
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th_e di.azo group and one of th_e electron-withdrawing groups attached 
to a methine carbon. c(-Diazosulfones (17) prepared by Van Leusen and 
Strating2 7 varied in stability up to a period of four months before 
undergoing decomposition. 
0-
G © ' 
N=N=CH-S-R I 0 
(17) 
Gilman and Jones2 8 showed that trifluorodiazoethane (18) was stable 
in solution at ordinary temperatures and an ether solution was kept 
for six weeks without undergoing any noticeable decomposition. 
G> @ 
N= N-=CH-CFs (18) 
The stability of a compound is a very important consideration 
when contemplating the dose level for the administration of the drug 
because of the reported toxicity of other glutamine antagonists. 
With increased stability, lower doses of the drug could be given. 
Work done by Jacques and Sherman2 9 suggested that an enzyme in mouse 
liver enzymatically degrades azaserine into ammonia and pyruvate. 
The reaction mechanism is probably an cA, a elimination wh�ch gives 
the acid, pyruvat·e, and aIIllilonia as end products. This was subs tan-
tiated by work done by Longenecker and Snell.30 They showed that 
pyridoxal and metal ions catalyze an rA., a elimination reaction of 
azaserine which gives the same reaction products as does the enzy-
matic breakdown of azaserine. 
The inhibitory effect of S-(l-diazo-2,2,2-trifluoroethyl) 
cysteine dioxide on the reaction of FGAR to FGAM is best explained 
by using French's mechanism (Scheme VI ) . Electron�withdrawing 
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Inhibitory- Effec t o f  
S- (l-diazo-2 , 2 , 2-trifluoroethyl) cysteine dioxide 
on FGAR Amidotransf erase 
H--S 
(Enzyme act ive s ite) 
(a)  
"' 
Q/ S 0 NH3 /' I I l / 
H- c - s - CH - CH-coo0 I I 2 '\ 
CF3 0 ' ,  
(d ) 
/':J 
H-S 
e�� 
---) N=N=C-
( 
Scheme VI 
1 
CF3 
,,,. 
� .... 0 NH3 ,,,,, I J / 
s - CH2- cH-cooe I ' 0 \ 
(b) 
(c) 
\ 
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groups also aid the attack of the nucleophilic sulfur on the pro­
tonated diazonium salt (see Scheme VI , fig . c) . Electron-withdrawing 
groups s tabilize the transition s tate in nucleophili.c subst itution 
by helping to dispers e the developing negative charge . 
The central reaction for the synthesis of S- (l-diazo-2 ,2 ,2-
trifluoroethyl) cys teine dioxide is an imine addition o f  pro tected 
cys teine . 
0 
0-11 
c, (9 ) 
N + 
ll c 
/' 
CF 3 H 
0 
, ,  
HS-CH2- CH-C-OC H I 2 s 
o � o (10 ) 
N-b enzoyl-2,2 , 2-trifluoro­
acet:aldillline 
N ,N-phthaloylcys teine ethyl es ter 
Combination of N-benzoyl-2 , 2 ,2-trifluoroacetaldimine ( 9 )  and N,N-
phthaloylcys teine ethyl es ter (10 ) and the ensuing react ions that 
give the f inal product can be followed on. Scheme VII . 
Our first  approach (Scheme VIII) to the synthes is_ of N , N-
phthaloylcys teine ethyl ester started with the amino acid, L-cystine.  
The amino group is pro tected by treatment of cys tine with carboethoxy 
phthalimide . 3 1  The phthaloyl group is used for protec tion b ecause 
of the eas e with which it can be removed by treatment with hydra-
zine .  The value of us ing phthalimide to protect the amino group is 
illustrat ed when the sulfone (12) is treated wi th nitrous acid to 
give the N-nitroso amide (13) . If the amino group were not pro-
tected , then the nitrous acid could attack the amino or amido group 
giving a lower yield of the desired product (13) . Very · poor yields 
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A Synthes.is of  
S- (l-di.azo-2,2,2-trifluoroethyl) cys t eine d ioxide 
1. Combinat ion of N-benzoyl-2,2,2-trifluoroacetaldimine with N,N'­
ph.thaloylcysteine ethyl ester will give S- (l-benzamido-2 ,2,2-
trifluoroethyl)-N ,N-phthaloylcys teine ethyl es t er (11). 
0 H H 0 
II I f 11 
@- C...i. N- C - S - CH2- CH- C-OC 2Hs (11) I l 
CF3 N\.. o�o 
2. Oxidi z ing (11) will give the suifone : S- ( l-benzamido-2,2,2-
trifluoroethyl) -N,N-phthaloylcys teine dioxide ethyl es ter (12) . 
0 H H 0 
" ' J , 
@)-c-N-C - S -
1 , 
CF3 0 
0 
II 
CH2 -CH- C - OC 2Hs ' 
N 0¥0 (12) 
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3. Treatment of (12) with nitrous acid will form the N-nitroso amide : 
S- (l-N ' -nitrosobenzamido-2,2,2-tri.fluoroethyl)-N,N-phthaloyl­
cysteine dioxide ethyl · es ter (13 ) . 
0 
rn\_ ll �c 
O : N 
H 0 
1 I 
N- C - S -
/ .  I I 
CF3 0 
0 
&I 
CH2- CH- C - OC 2Hs. I 
(13) 
N 0¥0 
4. Addition of sodium ethoxide to (13) will give the diazo group : 
S- (l-diazo-2,2,2-trifluoroethyl) -N,N-phthaloylcys teine dioxide 
ethyl es ter (14). 
0 0 
e e±> , " 
N = N = C - S - CH 2 - CH -C - OC 2Hs 
' ' ' 
CF, o 0�0 
Scheme VII 
(cont inued) 
(14) 
Scheme VII 
5. Trea tment of (14) with hydrazine wi ll remove the pht�aloyl group: 
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S- (l-diazo-2 ,2 , 2-trifluoroethyl) cys teine dioxide ethyl es ter (15). 
0 0 EJ (f} I 11 
N = N = C - S - CH 2- CH - C - OC 2H!5 I I � 
CF3 Q NH2 
(15 ) -
6 .  Addit ion of  base and then acid to (15) will remove the es ter to 
give S- (l-diazo-2 , 2 ,2-trifluoroethyl ) cys teine dioxide (16 ) . 
0 0 
.e G) I II 
N = N = C - S - CH2 - CH - C - OH I I I 
CFs 0 NH 2 
(16 )  
0 
" 
C-OH 
I 
H2N-CH 
I 
CH2 1 
Synthes is of  
N ,N-phthaloylcysteine ethyl es ter 
0 
II 
C-OH 
I 
H2N-CH 
I 
CH2 
I 
+ 
0 � rJ 
)-C-OC2H5 
II 
0 
s ----- s (N-carboethoxy phthalimide) 
(20) 
(L-cys tine) 
(19) 
0 
" 
,.. C-OH � l 
N-CH ( I 
CH2 
I 
s 
N , N ' -diphthaloyl cys t ine 
(21)  
0 0 
" u 
O C-OC H 0 C-OC2Hs 
�-�H 
2 5 �-�H reduct ion ) 
CH2 CH2 
l ' 
s -�----�--� s 
N , N ' -diphthaloylcys t ine ethyl es ter 
(22) 
Scheme VIII 
0 " 
0 C-OC2H5 �I I 
�. 'N-CH , ( I 
0 CH2 
I 
SH 
N , N-phthaloyl 
cys teine 
ethyl ester 
(10) 
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of the diazo analog are obtained w:h.en the cl-amino_ group is not pro­
tected during diazotization (15-20%) fo:r azas_erine12 and (6%) for 
DON.18 Th b 1 e car oxy group is protected.by treatment of N,N'-di-
phthaloylcystine with ethanol and hydrogen bromide gas to give the 
corresponding ester. The next step involves reducing the disulfide 
linkage. However, after many- different attempts to reduce the di­
sulf ide failed, a diff erent approach was tried. 
A second route (Scheme IX) to (10)  was planned. ·In this trial, 
we start with the amino acid, L-cysteine. The carboxyl group is 
esterified using the same method as before. Then, the sulfhydryl 
group is protected by treatment with dihydropyran.32 Af ter attach-
meut of the phthaloyl grou�, attempts ar� made t o  remove the tetra-
hydropyranyl group from sulf ur. Again, after many attempts of this 
reaction failed, we used the unprotected amino ester in the imine 
addition reaction. 
This third approach (Scheme X) involves the combination of 
N-benzoyl-2,2,2-trif luoroacetaldimine with cysteine ethyl ester 
hydrobromide. If one ccmpares the reactivity of the sulfhydryl 
group to the amino group, then this reaction should be quite f easi­
ble. The sulfur anion of cysteine ethyl ester is about 1290  times 
more reactive than the amino group when reacted with acrylonitrile. 33 
This -dif f erence in reactivities is explained in terms of polarizabil-
ities of nonbonded electrons on nitrogen and sulfur, charge distribu-
tions in ground and transition states and solvation f actors. The 
pK value for the sulfhydryl group is 6. 53, while the pK value f or the 
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S:ynthesis of 
N,N-ph.thaloylcysteine ethyl ester 
0 
" 
C-OH 
I 
H2 N-CH 
I 
CH2 ' 
SH 
L-cysteine 
( 23 )  
( 
(18) 
e Br 
0 
u (£) 9-0C2 Hs 
H3N-CH 
' 
CH2 
I 
SH 
cysteine ethyl ester 
hydrobromide 
(24)  
r'l>YR. 
ft 
� ( N-C-OC2Hs 
0 
0 
Dihydropyran 
N,N-phthaloyl-S­
(2-tetrahydropyranyl) 
cysteine ethyl ester 
(26) 
s-(2-tetrahydropyranyl) 
cysteine ethyi ester 
hydrobromide 
(25) 
N,N-phthaloylcysteine 
ethyl ester 
(10) 
Scheme IX 
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A Synthes.is of 
S-(l-diazo-2,2,2-trifluoroethyl)cysteine dioxide 
0 H 
II ! 
@-c-N=C 
I 
CF3 
N-benzoyl-2,2,2-
trifluoroacetaldimine 
(9) 
+ . 
cysteine ethyl ester 
hydrobromide 
(24) 
S-(l-benzamido-2,2,2-trifluoroethyl) 
cysteine ethyl ester 
(27) 
l follow pathway similar to Scheme VII 
O · 0 
Et3N 
triethylamine 
0 9 ' ll 
N=N=C -S -CH2- CH- C-OH (16 ) 
I I I 
CF3 0 NH2 
S-(l-diazo-2,2,2-trifluoroethyl)cysteine dioxide 
(16) 
·Scheme X 
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Synthesi.s . of  
N-Renzoyl-2 , 2 ,  2-Trifluor.oacetaldimine3 2 
OH 
I 
CFs-C-OH I 
H 
Trif luoro­
acetaldehyde 
hydrat e  
( 28 ) 
0 /;::.\ II 
\::Y-c, 
N 
II 
c /'-. 
CF3 H 
+ 
Benz amide 
(29 ) 
triethylamine 
N-benzoyl- 2 , 2 , 2-trifluoro­
acetaldimine 
(9) 
Scheme XI 
> 
OH. I 
CF3-C-H' 0 · 
I II � NH - C-  
N-benzoyl- 2 , 2 , 2-
trifluoro-l­
hydroxyethylamine 
. (30)  
Cl 
I 
CFrC-H 0 
I II ·NH - C -© 
N-benzoyl-2 , 2 , 2-
trifluoro-l­
chloroethylamine 
(31)  
2 7  
ammonium ion group ia 9.05. The sulfhydryl hydrogen is more acidic 
and thus , the sulfhydryl anion is present in larger . quant ity under 
the reaction conditions . · Becaus e N-benzoyl-2 , 2 , 2-trifluoroacetaldi.­
mine is very unstable , the precursor of the imine is utilized in 
the reaction.3 4 The formation of S- (l-benzamido-2 , 2 , 2-trifluoro­
ethyl ) cys t eine ethyl es ter follows a pathway similar to  Scheme VII 
to give the des ired product (16) . 
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RESULTS AND DISCUSS ION 
As previously mentioned , the synthesis of S- (l-diazo-2 , 2 , 2-
trifluoroethyl ) cysteine dioxide (16 )  by the combinat ion of N-benzoyl-
2� 2 ,  2-trif luoroacetaldimine ( 9 )  and N , N-phthaloylcysteine ethyl 
es ter ( 10) was desired . The synthesis of the imine will f irs t be 
discussed and the attempts to synthesize the protect ed cys t eine will 
follow. Also , attempts to combine a precursor of the imine with 
cysteine ethyl est er hydrobromide will be discusse4 . 
Synthesis of N-Benzoyl-2 , 2 , 2-Trifluoroacetaldimine 
The precursors of the imine , N-benzoyl-2 , 2 , 2-trifluoro-l-
hydroxyethylamine ( 30)  and N-benzoyl-2 , 2 , 2-trifluoro-l-chloro-
ethylamine (31 )  were prepared according to the procedure of  Weygand , 
S teglich and co-workers (Scheme XI). 3 2 
Preparation of  N-benzoyl-2 , 2 , 2-trifluoro-l-hydroxyethylamine 
( 3 0 )  was accomplished by reacting benzamide (29 ) and trifluoro-
acetaldehyde hydrate ( 28 )  with sulfuric acid in a sealed tube. The 
tube was placed in a pipe and heated for 12 hours at 80 ° C .  The 
produc t  was r emoved and washed with ethyl acetate and sodium bicar-
bonate solution. Evaporation of the ethyl acetate layer gave a 52% 
yield of  a white  crystalline solid that melted at  102-105 °C. The 
ir spec trum of  N-benzoyl-2 , 2 , 2-trifluoro-l-hydroxyethylamine ( 30)  
0 
" 
showed absorp t ion at 3410 (-OH) , 3310 (-NH), 1640 (amide I ,  -C-NH)  
0 
11 
and 1530 cm- 1 (amide II , -C-NH) . 
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The mass spectrum showed the molecular i.on at m/ e 219. . The 
cleavage o{ N-b enzoyl-2 , 2 ,2-t-ri.fluo:ro-l-�droxyethylamine (30)  gave 
possible fragments corresponding to the . m/e values and thei.r percent 
abundance (Table lI). 
Preparation of N-benzoyl-2 , 2 , 2- tr ifluoro-l-chloroethylamine (31 ) 
by adding phosphorous pentachloride to N-benzoy-1-2 ,  2 ,  2- trif luoro-1-
hydroxyethylamine (30 )  gave a 25% yield of a light b rown crys talline 
solid that melted at 88-91 °C. Care was exercis ed with the addition 
of phosphorous pentachlor ide to N-benzoyl-2 , 2 , 2- trifluoro-1-hydroxy-
ethylamine (30) becaus e it was a violent react ion. I t  was found that 
best r�sults were obtained when PC1 5 was slowly added to  30 in a 
beaker and the reagents were stirred .  The ir spectrum of N-benzoyl-
2 , 2 , 2-trifluoro-l-chloroethylamine (31) showed absorption at 
0 0 
u II 
3280 (-NH ) , 1660 (amide I, -C-NH) and 1525 cm- 1 (amid e  II, -C-NH) .  
The mass spectrum showed the molecular ion at m/e 237. The 
cleavage of N-b enzoyl- 2 , 2 , 2-trifluoro-1-chloroethylamine (31 ) gave 
poss ible fragments for the corresponding m/e values and their percent 
abundance (Tab le III) . 
Synthes is of the imine was done in situ during i ts addition with 
the thiol for the following reasons . Firs t ,  N-benzoyl- 2 , 2 , 2-tri-
fluoroac etaldimine (9 ) is uns table and not eas i ly isolated due to its 
high mois ture-s ensitivity. Secondly ,  9 is eas ily generated from 
its precursors so that it is not necessary to isolate the imine in a 
pure form.'"' 
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Table II  
Mass Fragments of 
m/e 
69 
77 
105 
121 
150 
219 
Percent 
Abundance 
9 
81 
100 
54 
5 
3 
OH 
I 
CFs-CH 0 I 
"
-© HN- C 0 
Possible Fragments 
[+] 
CFs 
C6Hs 
0 
"@ 
c 0 
0 II 
H2N-c-@ 
OH 
• 
CH 0 
I U-@ 
HN-C 0 
molecular ion 
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Table III 
Mass Fragments of 
m/e 
69 
77 
105 
202 
237 
239 
Percent 
Abundance 
5 
61 
100 
1 
3 
1 
Cl 
' 
CF3-CH 0 I II _r;:;\ 
HN-C '2_; 
Possible Fragments 
[+] 
0 
JI-® 
c 0 
H 
' 
CF3-C 0 I "-® 
HN-C 0 
molecular ion 
M+2 
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Synthes is of N , N-Phthaloylcys t eine Ethyl Es t er 
The preparation of  N , N-phthaloylcyst eine ethyl es t er (10 ) was 
firs t a ttempted by ut ilizing the amino acid , L-cys t ine (19 ) (Scheme 
VIII ) . The amino and carboxy group of L-cys tine (19 )  were  pro tected 
and then reduct ion of the disulfide was attempt ed . 
Phthaloyl pro tection for the amino group was achieved by  us ing 
the p roc edure of Nefkins , Tesser and Nivard . 3 1 Preparation o f  
N-carboethoxy phthalimide ( 20 )  was accomplished b y  dissolving 
phthalimide in dimethylformamide and triethylamine whi ch was 
treated with ethyl chloroformate at 5-10 ° C  with vigorous s tirring . 
Aft er the mixture reached room temperature (about 1 hour ) , i t  was 
poured into water. The product was filtered and gave a 57%  yi eld of 
a white  crys talline solid that melted at 78-79.5 °C . The ir s p ectrum 
of N-carboethoxy phthalimide (20 ) showed absorption at 1810 ( imide , 
0 0 
-�-N-� ) ,  1760  ( es t er ,  C=O) , 1600 (aromatic , -c==-c- ) and 720 cm- 1 
(aromat ic , C-H ) .  
L-cys t ine (19 ) was dissolved in sodium carb onate b y  gentle _ 
heating and was treated with N-carb oethoxy phthalimide ( 20 ) . The 
mixture was s t irred and the solution was filtered and ac idifi ed with 
- 6N hydrochloric acid. A milky white precipitate formed which was 
dissolved by heating . Slow cooling gave a 52% yield o f  N ,N ' -di- . 
phthaloyl-L-cys t ine (21) , a white crystalline product that melted 
at 117-119 °c . The ir spectrum of N , N ' -diphthaloyl-L-cys tine (21 ) 
33  
0 0 
showed abs orpt ion at 1770 (imide ,  -C-N-�- ) , 1700 (acid , C=O) , 16 20 
(aromat ic ,  -c==c- ) and 7 20 cm- 1 (aromatic , C-H) . 
The carboxyl group of (21)  was protected by making the ethyl . 
es ter following a modification of the procedure as found in Green­
s t ein and Winit z . 3 � Problems arose in finding an appropriat e  acid 
catalys t .  
The f irst attempt  involved suspending N , N ' -diphthaloyl-L-cys tine 
(21)  in abs olut e ethanol and then p-toluenesulfonic acid was added . 
The mixture was r efluxed for 24 hours and then filtered hot . The 
f iltrate was cooled and then filtered . The resulting f iltrate was 
evaporated in order to ·collect any more product . However , this pro-
cedure gave back s tarting material . 
The s econd trial utilized the same procedure excep t that con-
centrat ed sulfuric acid was subs tituted for p-toluenesulfonic acid . 
A s ticky r esidue was collected but could not be  success fully crys-
tallized . 
In the third attempt , concentrated hydrochloric acid was used 
and in les s er quantity than sulfuric ac.id . . This procedure gave back 
s tarting material . 
Cons equently , a s tream of hydrogen bromide gas was added to a 
susp ension of the N ,N ' -diphthaloyl-L-cys tine (21 )  in abs olute ethanol .  
N ,N ' -diphthaloyl-L-cys tine (21)  was immediately diss olved . The 
solution was then refluxed for 24 hours and filtered hot
.  The fil­
trate  was cooled for over 12 hours and f iltered gi
ving .a 70% yield 
of N , N ' -diphthaloyl-L-cystine ethyl ester (2
2) , a white crystalline 
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solid that melted at 8 7-89 ° C .  The ir spectrum o f  N , N ' -diphthaloyl-
0 0 
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L-cys tine ethyl est er (22 showed absorption a t  17 70 ( imide , -C-N-C-) , 
1740 and 1710 (ester , C=O) , 1610 (aromatic , -c==c- ) and 7 20 cm- 1 
(aromatic , C-H) . 
Reduction of the disulfide  linkage to give N , N-phthaloyl-L-
cys teine ethyl es t er (10) fail ed . Attempts to r educe · the disulfide 
will be discuss ed . 
In the first attempt , N ,N ' -diphthaloyl-L-cystine ethyl es ter (22)  
was treated with sodium and liquid ammonia . 3 6 A tes t  tube containing 
the es t er was placed in a dewar containing dry ice and acetone so  
that with the addition of  liquid annnonia , the mixture was cooled to  
-7 5 ° C . Sodium was added arid the mixture was s t irred without cooling 
for 1 1 / 2  hours . At that time , annnonium iodide was added and the 
ammonia allowed to evaporate . However , this procedure gave b ack 
s tart ing mat erial . 
In the s econd attemp t , the es ter was dissolved in hot absolute 
ethanol and mercaptoethanol3 7 was added . The s olut ion was r efluxed 
for 2 hours and kept under nitrogen atmosphere .  The solution was 
cooled but failed to give crys tals . The solution was refluxed again 
for 2 hours and cooled . Still , there were no crys tals , s o  water was 
added dropwis e  until the solut ion became cloudy . The solution was 
cooled again and product was collected . However , analys is by ir 
spect roscopy showed no -SH peak so that the disulfide linkage was not 
b roken . 
For the third trial ,  the e ster was dis solve d in warm glacial 
acetic acid and zinc dust3 8 was added s lowly in sma l l  am ount s . The 
mixture was b oi le d  until colorless and di luted with two vo lume s of  
wate r and filtere d .  The fi ltrate was cooled to give a pr oduct . 
Analysi s by ir showed no -SH peak so that the disul fi de wa s not 
cleaved and showed that the acid had attacked the phtha loyl group . 
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F ourthly , the acid (21) was di ssolve d in 3N hydr ochloric acid and 
tin3 9 was adde d .  The mixture was re fluxed for 2 hour s  and the n 
coole d .  The meta l wa s filtered off and two volume s o f  water were 
adde d  t o  the fi ltrate . The fi ltrate wa s cooled and a precipitate was 
collected b ut failed to show a -SH peak on the ir . The product iso­
late d was the s tarting materia l (21) . 
Hydr o genation 4 0 of the e ster wa s the n tried . The e ster in di oxane 
was hydrogenated at room t emperature in a Paar Shaker apparatus at an 
initia l pre s sure of 45 psi over 5% palladium on charc oa l . When the 
hydrogen uptake wa s complete (about 2 hours ) ,  the catalyst wa s re ­
moved by suction fi ltration . The fi ltrate was evaporated by use of  a 
Rinco to  give the pr oduct . Care was taken to ma ke s ure that the com­
pound wa s not oxidi ze d back to the di sulfide by over-exposure to .the 
. air . Analysi s by ir showed that the di sulfide was n ot reduced .  The 
reason for thi s fai lure may be due to the generally acce pted state ­
me nt that the e fficiency of  pa lladium or platinum a s  a cata lyst suf­
fer s  a marked dimin ution whenever sulfur is  pre sent . 
Las t  of  a ll , attempts were made to make the Bunte salt . 4 1  The 
e ster was dis s olved in ethanol and a 10% sodium sulfite s olution was 
slowly added . The solution was stirred well and placed in i ce to get 
crys tals . Analysis of the product formed by ir showed no -SH peak so 
that the disulfide was not cleaved . 
The inab ility to reduce the disulfide or form the Bunte salt may 
b e  due to s teric hinderance , but it cannot be  proven . 
S ince the disulfide link�ge of the N , N ' -diphthaloyl-L-cys tine 
ethyl es t er ( 22 )  was not cleaved by reduction , an alternative method 
(Scheme IX) was needed to synthesize N , N-phthaloylcys teine ethyl 
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est er (10 ) . Attachment of the es ter and tetrahydropyranyl groups to 
L-cys t eine ( 23 )  was accomplished according to the procedure of Holland 
and Cohen . 4 2 
Cys teine ethyl es ter hydrobromide ( 24 )  was prepared by suspending 
L-cysteine (23 )  in ethanol and the mixture saturated with hydrogen 
bromide gas . The mixture was stored for 12 hours at room temperature 
and concentrated under pressure . Diff iculty was · encountered with 
crys tallizat ion after evaporation .  Addition of ether to the res idue 
and reevaporation aided crys tallization . The product formed gave a 
91% yield o f  a white crystalline produce that melted at 94-97 °C . The 
ir s pectrum showed absorption at 2480 (-SH) and 1745  cm- 1 (es ter , 
C=O) .  A nitroprusside test was also run to prove the presence  of the 
-SH group . Cys t eine ethyl ester hydrobromide ( 24 )  gave a pos it ive 
resul t , a red-pink color . 
Treating cys teine ethyl es ter hydrobromide ( 24 )  in methylene 
chloride wi th dihydropyran gave a 92% yield of S- (2-tetrahydro­
pyranyl ) cysteine ethyl es ter hydrobromide (25 ) , a light
 b rown 
crystalline solid that melted at 122-123 °C . There was no need to re-
f lux the mixture of cysteine ethyl es te� hydrob romide ( 2 4 )  in methy­
lene chloride when dihydropyran was slowly added . Solution was imme-
diat e upon addition of dihydropyran. Again , ether was added to the . 
syrup in order to get crystals. The ability to get crys tals via this 
method diff ers from the work of Holland and Cohen . 4 2 They f ormed the 
hydrochloride methyl ester which was a res idual syrup that resisted a 
number of att empts at  crystallization . The ir s pectrum showed ab-
sorp t ion at 1745 cm- 1 (ester , C=O ) . Also , there was no -SH peak at 
The at tachment of the phthaloyl group followed a modification of 
3 1 the procedure of Nefkins and co-workers .  S- (2-tetrahydropyranyl )  
cysteine ethyl ester hydrob romide (25)  was dis s olved in triethylamine 
and water. N-carboethoxy phthalimide (20)  was added s lowly . The 
suspension was s tirred and heated until completely . diss olved . The 
solution was cooled giving a 23% yield of N ,N-phthaloyl-S- (2-tetra-
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hydropyranyl) cysteine ethyl ester (26 ) , a whit e crys talline solid that 
melt ed at 200-205 °C . The ir spectrum showed abs orption at 17 70 
0 0 
(imide , -5-N-�-)  and 1750 cm- 1 (es ter , C=O) . 
The mass  spectrum showed the molecular ion at m/e 3 6 3. The 
cleavage o f  N ,N-phthaloyl-S- ( 2-tetrahydropyranyl ) cys t eine ethyl 
ester (26 ) gave possible fragments corresponding to the m/e values 
(Table IV) . 
Table IV 
�as s  Fragments of 
Percent 
m/e Abundance 3lf 
205 100 
290  20  
363  8 
Pos s ib le Fragments 
[+] 
0 
@(�- CF 
( ! 
CH2 I 
s 
0 " 
@(N-cH r"' I O CH2 I 
CY 
molecular ion 
� . 
· m/e 205 was used as the bas e peak because the fra
gments of  lower 
m/e - value were  all off scal e .  This was due to the fact that 
difficulty was exp erienced in obtaining the molecular ion peak . 
39 
Attempts  to  r emove the tetrahydropyranyl group failed . The 
treatment of N , N-phthaloyl-S- (2-tetrahydropyranyl) cys t eine ethyl · 
es ter ( 2 6 ) with different reagents will be discussed . 
In the. first  attempt , an alcoholic solution of  N , N-phthaloyl­
S- (2- t etrahydropyranyl) cys teine ethyl es ter ( 26 )  was t reated with 
s ilver nitrate  s olution at O �C . 42 Analysis by ir showed that the 
material isolated was not the silver salt but the s tart ing material . 
Secondly , 26 was dissolved in ethanol and treated with generated 
H2S gas . The solution was cooled to collect crys tals . Analys is by 
ir showed that the material isolat ed was still the s tarting material . 
In the article by Kipnis and Ornfelt , 4 3 they s tated that the 
tetrahydropyranyl sulfides are in reality s emimercaptals , which are 
uns tab le to acids . Cons equently , at tempts to remove the tetrahydro­
pyranyl group by treatment with acids were made .  
N , N-phthaloyl-S- (2�tetrahydropyranyl ) cys teirte· e thyl es ter (26 ) 
was dissolved in ethanol and treated wi th hydrogen bromide gas . The 
s olution was cooled and the product collected . Analys is by ir showed 
that the material isolated was the starting material . 
Again , an alcohol solution of N , N-phthaloyl-S- ( 2-tetrahydro-
pyranyl ) cys t eine ethyl ester (26 ) was treat ed with hydrogen b romide 
gas . However , this time the solution was refluxed for an hour .  The 
solut·ion was cooled and the produc t collected . Analys is by ir showed 
that the mate.rial isolated was still the starting mat er ial . 
Finally , 26 was dissolved in ethanol and was tr
eated with 10% 
hydrochloric acid solution . The resulting solu
tion was· s tirred and 
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cooled and the product collec ted . Analys is by ir showed that the 
material isolated was s till the starting mater ial . 
The failure to r emove the tetrahydropyranyl group from N , N­
phthaloyl-S.- ( 2-tetrahydropyranyl ) cys teine ethyl es ter ( 2 6 )  canno t be 
explained by this au thor . Although there may be  s teric hinderance , 
treatment with acid should have removed the tetrahydropyranyl group . 
Because at temp ts to synthesize N , N-phthaloylcys teine ethyl ester 
(10) failed , other means to ob tain 10 were tried (Scheme X) by treat� 
ment of the unprotected amino ester with the imine .  As ment�oned 
before , precursors of the imine can be ut ilized when trea ted with 
nucleophilic reagents . 
In the fir�t  ::lttemp t , cys teine ethyl es te:r- hydrab:r-c!!!id e ( 24 ) i;·:ras 
dissolved in triethylamine and methylene chloride . N-benzoyl-2 , 2 , 2-
trifluoro-l-chloroethylamine (31) was slowly added . 3 2 Produc t was 
innnediately formed upon this addition . Analys is by ir of  the product 
formed was complica ted by the presence of the triethylammonium bro­
mide .  This react ion was tried again substituting d ioxane for methy­
lene chlor ide  as the solvent but achieved the same results : 
Nex t , an alternative was attempted which utilizes the trifluoro­
acetate which eliminates to form the imine . Neither the imine nor 
.trifluoroacetate were isolated . N-ben
zoyl-2 , 2 , 2-trifluoro-l-hydroxy­
ethylamine (30 )  was dissolved in pyridine , cooled in ice and tri­
fluoroacetic anhydride (TFAA) was added . Care was exercised at this 
point becaus e TFAA reac ts quite vigorously with the s olution . After 
five minutes , cys teine ethyl es er hydrobromide (24 ) was
 added and 
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the mixture was stirred . The solution s tood at room temperature for 2 
hours . Ethyl acetate was added and the solution was placed in a 
separatory funnel . The ethyl acetate layer was separa ted upon addi-
tion of sodium bicarb onate solution . The ethyl acetate layer was 
dr ied over anhydrous magnesium sulphate .  Evaporation o f  ethyl ac e-
tate and pyridine was done in vacuum . 4 4  An oily r es idue was left  
which was very d iff icult to  crystalliz e .  Some success was achieved 
with carbon tetrachlor ide . However , this procedure only gave a 4% 
yield of S- ( l-benzamido-2 , 2 , 2-trifluoro ethyl) cyst eine ethyl es ter ( 27 ) , 
a white  crys tall ine produc t that melted at 91-94 °C . The ir spectrum 
showed absorption at 3360 (-NH) , 317 0 (-NH2 ) ,  17 50 (es ter , C=O) , 1650 
0 0 
" f l  
(amide I, -C-NH) and 1580  cm- 1 (amide II , -C-NH) . 
Tne mass  spectrum showed the molecular ion at m/e  350 .  The 
cleavage of S- (l-b enzamido-2 , 2 , 2-trifluoroethyl ) cys teine ethyl ester 
(27 ) gave pos sible fragments for the corresponding m/e values and 
their p ercent abundanc e (Table V ) . 
Because of the poor yields obtained in the preceding procedure 
in attempts  to crys tallize the residue , synthesis of  the sulphone 4 5 
was attemp ted , without crystallization . 
The residue was dissolved in glac ial acetic ac id and was cooled 
in ice .  Addition of acetic anhydride and 30% hydrogen peroxide was 
added
.
d ropwis e over a period of thirty minutes . The solution was 
4 h · · The solution was heated for 1 allowed to s tand for ours in ice . 
hour at 47 °c . This was allowed to stand to form crys tals .  An oily 
Mas s  Fragments of 
m/e 
69 
77 
105 
121 
133 
202 
261 
277 
350 
Table V 
0 H H 0 
" , , . ,, /;;\..._ C- N - c -s- CH 2 - CH - C  - O C2Hs '\::Y I f 
Percent 
Abundance 
10 
69 
100 
11. 5  
2 
3 
CFs NH2 
Poss ib l e  Fragments 
[+J 
CF s 
C 6 H5 
0 
" -@  c 0 
0 . " 
H2N-c-@ 
0 H H 
®- "  f ' 
C - N - C 
0 H H 
©- "  I I 
C - N -7 
CF 3 
0 H H 
2 
@- "  ' ' C - N -y - S - CH 2 - CH 
2 
. 35 
CFs 
0 H H 
®- ,, ' f C - N -C - S - CH2 - CH I f 
CF3 NH2 
molecular ion 
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res idue was left which resisted numerous attempts at crys tallization .  
Some s ucces s seemed likely when the res idue was dissolved i n  alcohol 
and ether was added . Crystals formed but when f iltered , the crys tals 
turned back to an oil . There existed the possib ility that there was 
a comb inat ion of products . The oily res idue obtained in 83% yield 
was analyzed by ir spectros copy and showed abs orption at  1740 (ester ,  
0 0 
I I  \ I  
C=O) , 1670 (amide I ,  -C-NH) , 1580 (amide II , -C-NH) , 1190 and 1050 
cm- 1 (sulfoxide ,  S=0) . 4 6 Therefore , instead of complete oxidation to 
the sulfone , most  of S- (l-b enzamido-2 , 2 , 2-trifluoroethyl ) cys teine 
ethyl es ter (27 ) was converted to the sulfoxide . The lack o f  com-
plete oxidation to the sulfone may be due to ster ic h inderance and/or 
the need for more vigorous conditions such as us e of ammonium molyb-
date catalys t 4 7 and /or s tronger heating . 
With the synthes is of the sulfoxide , only one prob lem remains 
in the synthesis of the glutamine analog ,  that is the diazotization . 
Actually , the sulfoxide represents a potent ial glutamine analog it-
self and should be inves tigated for inhib itory propert ies . · 
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EXPERil1ENTAL 
The work r eported . herein was done in residence at South Dakota 
S tate University , Brookings , South Dakota . 
Descript ion of Ins trwnentat ion Used : 
Infrared spectra were ob tained on a Perkin-Elmer Model 7 00 
Infrared Spectrophotometer between sodium chloride plates . All 
samples were solids and run in nuj ol phas e .  
Mas s  spectra were run on a Finnigan 3000 Mas s  Spectrometer . 
I .  Synthesis of N-Benzoyl-2 , 2 , 2-Trifluoroacetaldimine : 
A. N-Benzoyl-2 , 2 , 2-trifluoro-l-hydroxyethylamine : (30 ) 
The procedure as reported by Weygand , Steglich and co-workers 3 2 
was us ed to prepare N-benzoyl-2 , 2 , 2-trifluoro-hydroxyethylamine . A 
white  crys talline product was obtained that melted at 102-105 °C . 
Infrared absorpt ion bands appeared at 3410 (-OH ) , 3 310 (-NH) , 
� ?. 
1640 (amide I ,  -C-NH) and 1530 cm- 1 (amide II , -C-NH ) . 
The mass  spectrum gave a molecular ion at m/e  219 . The follow-
ing fragments were also  not ed : m/e 150 , m/e 121 , m/e  105 , m/e  7 7  
and m/e 6 9 . 
Yield = 9 . 46 g % Yield = 52% 
B.  N-Benzoyl-2 , 2 , 2-trifluoro-l-chloroethylamine : ( 3 1 )  
Th e  procedure as reported by Weygand , Steglich and co-workers 3 2 
was us ed to prepare N-benzoyl-2 , 2 , 2-trifluoro-l-chloroethylamine . 
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A l ight b rown crys talline product waa ohtained that melted at 88-9 1 °C .  
Inf rared ab sorption bands appeared . . at" 3280 (-NH) , 1660  (amide I ,  
0 0 II 1 1  
-C-NH) and 1525 cm- 1 (amide II,  -C-NH) . 
The mas s  s pec trum gave a molecular ion at m/e 237 .  The isotopic 
abundance of  the M + 2 peak shows the compound contains one chlorine . 
The following fragments were als o  noted : m/e 202 , m/e 105 , m/ e  7 7  
and m / e  69 . 
Yield = 2 . 47 g % Yield = 25% 
I I . Synthes is o f  N , N-Phthaloylcys teine Ethyl Ester :  
P�r t I .  
A .  N-Carboethoxy phthal imide : (20)  
The procedure as reported by Nefkins , Tess er and Nivard 3 1 was 
used to prepare N-carboethoxy phthalimide . A whi te crys talline 
produc t was ob tained that melted at 78- 79 . 5 °C .  
0 0 n u .
Infrared absorpt ion bands appeared at  1810 (imide ,  -C-N-C- ) , 
1760 (ester , C=O) , 1600 (aromatic , -c=-=c- ) and 720 cm- 1 (aromatic , 
C-H) . 
Yi eld = 125 . 14 g % Yield = 5 7 %  
B .  N,N ' -Diphthaloyl-L-cys tine : (21) 
.The procedure as reported by Nefkins , Tess er and Nivard 3 1 was · 
used to prepare  N , N ' -diphthaloyl-L-cys tine . A white crys talline 
product was ob tained that melted at 117-119 °C . 
. ' .  
- . . . . - � .  . . . . .. -�. .. . . . . . . . . 
9. P. Infrared . ahsorption hands appeared at 1770 ( imide ,  -C-N-C-) ,  
1700 (acid , C=O) , 1620 . (aromatic , -c=c-) and 720  cm-i (aromatic , 
C-H) . 
Yield = 5 . 43 g % Y-ield = 52% 
C • . N , N ' -Diphthaloyl-L-cys t ine ethyl es ter : ( 22 )  
An adap tion of  the method utilized by  Cur t ius and Goebel for 
est erificat ion of the carboxyl group as found in Greens tein and 
Winitz 3 5 was us ed for preparation of N , N ' -diphthaloyl-L-cys t ine 
ethyl es t er . 
A s tream of  hydrogen bromide gas was added to the suspens ion of  
2 . 0  g (0 . 004 moles ) of N , N ' -diphthaloyl-L-cys t ine in  100  ml  of  
abs olute  ethanol . The suspension was immediat ely dissolved and the 
solution was refluxed for 24 hours . The solution was f iltered while 
hot and the fi ltrate was cooled for over 12 hours . The resulting 
precipitate was filtered giving a white crys talline product that 
melt ed at 8 7-89 °C . 
n . o if I I  
Infrared ab s.orption bands appeared at 1770 (imide , -C-N-C ) , 
1740 and 1710 (ester , C=O) , 1610 (aromatic , -c==c- ) and 7 20 cm- 1 
(aromatic , C-H) . 
Yield = 1 .  55 g % Yield = 70% 
Part II . 
D .  Cys teine ethyl es ter hydrobromide : (24)  
The procedure as  reported by Holland and Cohen4
2 was used to  
prepare  cys teine ethyl es ter hydrobromide .  A white c rystalline 
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' '  
. . . . . -;: 
. . . .. ... -�:- . . . . . . 
product was obtai ned tha t melted a t  - 9 4�9 7 ° C . 
Infra red abs.orpt i.on ba nds. appea red at 248Q .(-Sli) and 1 7 45 cm ... 1 
(ester , C= O) . 
A nitroprus side t est was a lso run on cysteine ethyl ester 
h ydrob r omi de a nd gave a posi tiv e result ( red- pink color) indi cative 
of a -SH group . 
E. S -(2-t et ra hydropyrany l) cyst eine et hyl est er hydrobromi de: ( 25 )  
Continuati on of the procedure by Holland a nd Cohen4 2 was used 
to p repa re S - ( 2-tetrah ydropyra nyl) cyst ei ne et hyl ester hydrobromide. 
A l i ght brown crysta lli ne product was obtained that melted at 1 22-
1 23 ° C . 
In fra red ab sorpti on ba nd a ppea re d  a t  1 7 4 5  cm-1 (ester , C=O ) , 
Al so ,  there was no -S H peak a� 24 80 cm- 1 • 
Yield = 4 3 . 25 g % Y i eld = 9 2% 
F.  N , N-Ph t haloyl-S -( 2-t etra hydropyranyl) cyst eine et hyl ester : ( 26 )  
The p rocedure used f or the a ttachment of the p htha l oyl group 
was a modi f ica t ion of Nefki ns a nd co-workers . 3 1 S - ( 2-tetra hydropyra n­
yl ) cyst ei ne et hyl. ester hydrobromide [6 .  30 g (0 . 0 2  mol es)] was 
d i ssolved i n  3 . 0  ml (0 . 0 2  moles) of tri ethylamin e  a nd 30 ml of water. 
N-ca rb oet hoxy phtha limi de [4 .  50 g (0 . _0 2  mol es� was a dded slowly. 
Th e  susp en si on was sti rred a nd heated unti l completel y dissolv ed. 
The soluti on was cooled givi ng a white crysta l li ne product that 
mel t ed a t  20 0 -205 ° C . 
g 0 
Infrared absorpt ion ba nds appea red a t  1 7 7 0  (imi de , .  -
C -N-� ) 
a nd 1 7 5 0  cm- 1 (ester , C= O) . 
4 8  
. . • • 
• � •. • . •• . • t!'- • • • • • • • 
' .  
The mass spectrum gave a molecular ion at  m/e 363 . The follow­
ing f ragments were also noted : m/e 29 0 ,  m / e  205 . 
Y�eld = 1 . 60 g % Yield = 23% 
III . Synthesis of S- (l-Benzamido- 2 , 2 , 2-. 
Trifluoroethyl) cys teine E thyl Es ter : 
A. S- (l-Benzamido-2 , 2 , 2-trifluoro ethyl ) cys t eine ethyl es ter : ( 2 7 ) 
A modification of the procedure as r eport ed by Weygand and co­
workers 44 was used to prepare S- (l-benzamido- 2 , 2 , 2-trifluoroethyl )  
cys teine ethyl es ter .  
N-benzoyl- 2 , 2 , 2-trifluoro-l-hydroxyethylamine [2 . 20 g (0 . 01 
moles )] was dis solvad in approxiraataly 5 ml of pyridine . The s olu-
tion was cooled in ice and 1 . 4  ml of trifluoroacetic anhydr ide was 
added with care . Cys teine ethyl ester hydrob romide [2 . 30 g (0 . 01 
moles 5.J was added to the solution after f ive minutes . The mixture 
was s t irr ed and the solut ion was left to s tand for 2 hours at room 
temperature . Ethyl ac etate was added and the s olution was p laced in 
a separatory funnel . Separation of the ethyl acetate layer was 
achieved upon addition of sodium bicarbonate  solution and the ethyl 
acetate layer was dried over anhydrous magnesium sulfat e .  E thyl 
· acetate and pyridine were evaporated off in vacuum which lef t  an 
oily . res idue ( crude  product ) that was very difficult to crys talliz e .  
Some succes s  was achieved with carbon tetrachloride which gave a 
whi te  crys talline product that melted at 9 1-94 °C .  
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Infrared absorption b ands appeared at 3360 (-NH) , 3170 (-NH2 ) ,  
0 
1750 (es t er , C=O ) , 1650 (amide I ,  -e-NH) and 1580 cm- 1 (amide II , 
0 
" 
-C-NH) . 
The mass spec trum showed the molecular ion a t  m/e 3 50 . The 
following fragments were also -no ted : m/e 277 , m_/ e  261 , m/e 202 , 
m/e 121 , m/e 105 , m/ e 77  and m/e 69 . 
Yield = 3 . 0  g 
(crude product )  
Yield = 0 . 125 g 
(crys tallized product ) 
% Yield = 86% 
% Yield = 4%  
B .  S- ( l-Benzamido-2 , 2 , 2-trifluoroethyl ) cysteine oxide ethyl es ter : 
A mod ifi cat ion of the proc edure by Weygand and St eglich 4 5  was 
used to prepare S- (l-benzamido-2 , 2 , 2-trifluoroethyl ) cys t eine oxide 
ethyl ester . 
The c rude product (3 . 0  g )  of  S- (l-b enzamido-2 , 2 , 2-trifluoro-
ethyl ) cys t eine ethyl es ter was dissolved in 50 ml of  glacial acetic 
acid . The solut ion was cooled in ice and 15 ml of  acetic anhydride 
was added . Hydrogen peroxide (30% ) (10 ml) was added d ropwise over 
a period of thirty minut es . The solut ion was allowed to s tand for 4 
hour.s in ice and then was heated for 1 . hour at 4 7 °C . An oily res idue 
(crude product)  was left which res is ted numerous attemp t s  at crys-
tallization . Some success seemed likely when the res idue was dis-
solved in alcohol and ether was added . Crystals formed but when 
f iltered , the crys tals turned back to oil . Some crys tals formed from 
50 
water-acetone . The product is very soluble in water and alcohol and 
insoluble  in o ther organic solvents .  
Infrared absorption bands appeared at 1740  ( es t er , C=O) , 1670  
0 0 , ,  J.! (amide I ,  -C-NH ) , 1580 (amide II , -�-NH) , 1190 and 1050 cm- 1 
(sulfoxide ,  S=O ) . 
Yield = 3 . 0  g 
(crude produc t )  
% Yield = 83% 
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SUMMARY 
Although the synthesis of the des ired potential glutamine antag­
onist  was not completed , much knowledge was gained in wo�king with 
these compounds that warrants further investigat ion . 
The mos t  encouraging results occurred when the imine comb ined 
with cys teine ethyl ester hydrobromide to give S- (l-b�nzamido- 2 , 2 , 2-
trifluoroethyl ) cys teine ethyl ester . Partial oxidat ion o f  this com­
pound gave the corresponding sulfoxide which repres ents  a potential 
glutamine antagonist . Thes e  compounds could be used to  inves tigate 
theories about the mechanism of the amidotrans f erase catalyzed reac­
t ions . They may also be  ab le to show what kind of bonding s it es 
exist  at  and near the ac tive s ite of the amido trans ferase enzyme .  
This typ e  o f  inves t igation may lead directly to an ant imetab olite 
which is s elec t ively ac tive agains t tumor cells . 
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